MedPath

Thyrotropin alfa

Generic Name
Thyrotropin alfa
Brand Names
Thyrogen
Drug Type
Biotech
CAS Number
194100-83-9
Unique Ingredient Identifier
AVX3D5A4LM

Overview

Thyrotropin alfa is a recombinant form of thyroid stimulating hormone used in performing certain tests in patients who have or have had thyroid cancer. It is also used along with a radioactive agent to destroy remaining thyroid tissue in certain patients who have had their thyroid gland removed because of thyroid cancer. It is a heterodimeric glycoprotein comprised of two non-covalently linked subunits, an alpha subunit of 92 amino acid residues containing two N-linked glycosylation sites and a beta subunit of 112 residues containing one N-linked glycosylation site. The alpha subunit of thyrotropin alfa, which is the effector region responsible for the stimulation of adenylate cyclase, displays close structural similarity with the alpha subunit of human chorionic gonadotropin (hCG), luteinizing hormone (LH), and follicle-stimulating hormone (FSH). The beta subunit (TSHB) bestows its receptor specificity due to the uniqueness to TSH. The amino acid sequence of thyrotropin alfa is identical to that of human pituitary thyroid stimulating hormone.

Background

Thyrotropin alfa is a recombinant form of thyroid stimulating hormone used in performing certain tests in patients who have or have had thyroid cancer. It is also used along with a radioactive agent to destroy remaining thyroid tissue in certain patients who have had their thyroid gland removed because of thyroid cancer. It is a heterodimeric glycoprotein comprised of two non-covalently linked subunits, an alpha subunit of 92 amino acid residues containing two N-linked glycosylation sites and a beta subunit of 112 residues containing one N-linked glycosylation site. The alpha subunit of thyrotropin alfa, which is the effector region responsible for the stimulation of adenylate cyclase, displays close structural similarity with the alpha subunit of human chorionic gonadotropin (hCG), luteinizing hormone (LH), and follicle-stimulating hormone (FSH). The beta subunit (TSHB) bestows its receptor specificity due to the uniqueness to TSH. The amino acid sequence of thyrotropin alfa is identical to that of human pituitary thyroid stimulating hormone.

Indication

For detection of residueal or recurrent thyroid cancer

Associated Conditions

  • Thyroid Cancer

FDA Approved Products

Thyrogen
Manufacturer:Genzyme Corporation
Route:INTRAMUSCULAR
Strength:0.9 mg in 1 mL
Approved: 2023/02/24
NDC:58468-0030

Singapore Approved Products

Thyrogen 0.9 mg Powder for Solution for Injection
Manufacturer:Genzyme Corporation, Genzyme Ireland Limited (Fill-finish)
Form:INJECTION, POWDER, FOR SOLUTION
Strength:1.1 mg
Online:Yes
Approved: 2005/12/27
Approval:SIN13164P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath